At Philips, we look beyond technology to the experiences of the people at the heart of care – patients, clinicians and care givers – to unlock insights across the patient journey. We are dedicated to helping you address your challenges by partnering to create meaningful innovations.
Philips incorporates Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to advance early lung cancer diagnosis
What's trending
@PhilipsHealth
News
Philips incorporates Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to advance early lung cancer diagnosis
Click here to learn moreThe importance of surveillance-level data monitoring in hospitals
Click here to learn morePhilips and Nicolab host joint symposium on the future of stroke treatment at ESOC 2022
Click here to learn more